Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase

Br J Pharmacol. 2000 Mar;129(6):1194-200. doi: 10.1038/sj.bjp.0703144.

Abstract

1. The contribution of an endothelium-derived hyperpolarizing factor (EDHF) was investigated in saphenous and mesenteric arteries from endothelial nitric oxide synthase (eNOS) (-/-) and (+/+) mice. 2. Acetylcholine-induced endothelium-dependent relaxation of saphenous arteries of eNOS(-/-) was resistant to N(omega)-nitro-L-arginine (L-NNA) and indomethacin, as well as the guanylyl cyclase inhibitor, 1H-(1,2,4)oxadiazolo(4,3-a) quinoxalin-1-one(ODQ). 3. Potassium (K(+)) induced a dose-dependent vasorelaxation which was endothelium-independent and unaffected by either L-NNA or indomethacin in both saphenous and mesenteric arteries from eNOS(-/-) or (+/+) mice. 4. Thirty microM barium (Ba(2+)) and 10 microM ouabain partially blocked potassium-induced, but had no effect on acetylcholine-induced vasorelaxation in saphenous arteries. 5. Acetylcholine-induced relaxation was blocked by a combination of charybdotoxin (ChTX) and apamin which had no effect on K(+)-induced relaxation, however, iberiotoxin (IbTX) was ineffective against either acetylcholine- or K(+)-induced relaxation. 6. Thirty microM Ba(2+) partially blocked both K(+)- and acetylcholine-induced relaxation of mesenteric arteries, and K(+), but not acetylcholine-induced relaxation was totally blocked by the combination of Ba(2+) and ouabain. 7. These data indicate that acetylcholine-induced relaxation cannot be mimicked by elevating extracellular K(+) in saphenous arteries from either eNOS(-/-) or (+/+) mice, but K(+) may contribute to EDHF-mediated relaxation of mesenteric arteries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology*
  • Animals
  • Apamin / pharmacology
  • Arteries / drug effects
  • Barium / pharmacology
  • Biological Factors / pharmacology
  • Charybdotoxin / pharmacology
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Mesenteric Veins / drug effects
  • Mice
  • Mice, Knockout
  • Muscle Relaxation / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / deficiency*
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nitroarginine / pharmacology
  • Ouabain / pharmacology
  • Peptides / pharmacology
  • Potassium / pharmacology*
  • Potassium Channel Blockers
  • Potassium Channels*
  • Potassium Channels, Inwardly Rectifying*
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors

Substances

  • Biological Factors
  • Enzyme Inhibitors
  • Kcnj10 (channel)
  • Peptides
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • endothelium-dependent hyperpolarization factor
  • Charybdotoxin
  • Nitroarginine
  • Apamin
  • Barium
  • Ouabain
  • iberiotoxin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Sodium-Potassium-Exchanging ATPase
  • Acetylcholine
  • Potassium